Health Catalyst, Inc., a provider of data analytics technology and services for healthcare organizations, has announced the successful acquisition of Lumeon Limited, a digital health company with a significant presence in both the United States and the United Kingdom. This strategic acquisition aims to revolutionize care coordination by combining Lumeon’s automated care orchestration platform with Health Catalyst’s advanced data analytics capabilities.
Healthcare providers in the U.S. and U.K. extensively use Lumeon’s Care Orchestration technology to reduce costs, optimize clinician efficiency, enhance revenue, and improve patient safety and care quality. By combining this platform with Health Catalyst’s AI-powered Ignite data processing capabilities, the company aims to deliver a more intelligent and robust solution for clinical improvement and ambulatory operations through the acquisition.
This integration will also bolster Health Catalyst’s Tech-Enabled Managed Services (TEMS) offerings, further supporting its mission to drive measurable healthcare improvements.
The acquisition not only strengthens Health Catalyst’s existing portfolio but also provides a strategic entry point into the U.K. market, positioning the company to explore new international opportunities.
Health Catalyst funded the acquisition through a combination of stock and cash, with further details provided in the company’s recent Quarterly Report on Form 10-Q, filed with the SEC on August 7, 2024.
Health Catalyst continues to lead the way in healthcare data analytics, empowering organizations to make informed decisions that drive clinical, financial, and operational improvements. The acquisition of Lumeon underscores Health Catalyst’s commitment to expanding its global footprint and enhancing its technology offerings to better serve healthcare providers worldwide.
More details at www.healthcatalyst.com
